Replies to post #7823 on Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

Google "Somaxon buyout" for a history on Pascoe.

I don't see any issues or parallels. Pascoe seems competent and focused. But you play the hand you are dealt. I think Apricus represents a good hand for Pascoe to play.

Regarding the ED market in France, this was a statement made a year ago: "Specifically for Vitaros®, we intend to market the drug ourselves starting next year in France and we currently expect that at our peak we may capture approximately 30% of the ED market in that country if the drug is approved.

According to IMS Health, the ED market in France is one of the largest in Europe, at €130 million ($163.8 million) in 2010."

Now, it turns out that Scomedica was a bust so Apricus won't direct market in France. But the optimism of capturing 30% of that market is based on the large alprostadil use there. Would you rather inject with a needle or a three second rub?